GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Thermo Fisher Scientific Inc (NYSE:TMO) » Definitions » Equity-to-Asset

TMO (Thermo Fisher Scientific) Equity-to-Asset : 0.49 (As of Sep. 2024)


View and export this data going back to 1980. Start your Free Trial

What is Thermo Fisher Scientific Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Thermo Fisher Scientific's Total Stockholders Equity for the quarter that ended in Sep. 2024 was $48,972 Mil. Thermo Fisher Scientific's Total Assets for the quarter that ended in Sep. 2024 was $100,364 Mil. Therefore, Thermo Fisher Scientific's Equity to Asset Ratio for the quarter that ended in Sep. 2024 was 0.49.

The historical rank and industry rank for Thermo Fisher Scientific's Equity-to-Asset or its related term are showing as below:

TMO' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.43   Med: 0.48   Max: 0.54
Current: 0.49

During the past 13 years, the highest Equity to Asset Ratio of Thermo Fisher Scientific was 0.54. The lowest was 0.43. And the median was 0.48.

TMO's Equity-to-Asset is ranked worse than
60.79% of 227 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.6 vs TMO: 0.49

Thermo Fisher Scientific Equity-to-Asset Historical Data

The historical data trend for Thermo Fisher Scientific's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thermo Fisher Scientific Equity-to-Asset Chart

Thermo Fisher Scientific Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.51 0.50 0.43 0.45 0.47

Thermo Fisher Scientific Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.47 0.47 0.47 0.48 0.49

Competitive Comparison of Thermo Fisher Scientific's Equity-to-Asset

For the Diagnostics & Research subindustry, Thermo Fisher Scientific's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Thermo Fisher Scientific's Equity-to-Asset Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Thermo Fisher Scientific's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Thermo Fisher Scientific's Equity-to-Asset falls into.



Thermo Fisher Scientific Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Thermo Fisher Scientific's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=46735/98726
=0.47

Thermo Fisher Scientific's Equity to Asset Ratio for the quarter that ended in Sep. 2024 is calculated as

Equity to Asset (Q: Sep. 2024 )=Total Stockholders Equity/Total Assets
=48972/100364
=0.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Thermo Fisher Scientific  (NYSE:TMO) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Thermo Fisher Scientific Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Thermo Fisher Scientific's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Thermo Fisher Scientific Business Description

Address
168 Third Avenue, Waltham, MA, USA, 02451
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of end-2023 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (10%); life science solutions (23%); and lab products and services, which includes CRO services (54%).
Executives
Marc N Casper officer: Senior Vice President C/O THERMO FISHER SCIENTIFIC, 168 THIRD AVENUE, WALTHAM MA 02451
Lisa P. Britt officer: Sr. VP and Chief HR Officer 168 THIRD AVENUE, WALTHAM MA 02451
Joseph R. Holmes officer: VP & Chief Accounting Officer 168 THIRD AVENUE, WALTHAM MA 02451
Gianluca Pettiti officer: Executive Vice President C/O BUTTERFLY NETWORK, INC., 530 OLD WHITFIELD STREET, GUILFORD CT 06437
Michael A Boxer officer: Sr. VP and Gen. Counsel 168 THIRD AVENUE, WALTHAM MA 02451
Michel Lagarde officer: Senior Vice President 450 LEXINGTON AVE., 31ST FLOOR, NEW YORK NY 10017
Stephen Williamson officer: Sr. VP and CFO 81 WYMAN STREET, WALTHAM MA 02451
Debora L Spar director C/O GOLDMAN, SACHS & CO., 200 WEST STREET, NEW YORK NY 10282
Jennifer M Johnson director C/O FRANKLIN RESOURCES, INC., ONE FRANKLIN PARKWAY, SAN MATEO CA 94403-1906
Jim P Manzi director 81 WYMAN ST, POST OFFICE BOX 9046, WALTHAM MA 02454
Ruby R Chandy director 630 DUNDEE ROAD, SUITE 400, NORTHBROOK IL 60062
Mark P Stevenson officer: Executive Vice President 850 LINCOLN CENTRE DRIVE, FOSTER CITY CA 94404
R. Alexandra Keith director ONE PROCTER & GAMBLE PLAZA, CINCINNATI OH 45202
Peter E Hornstra officer: Chief Accounting Officer 81 WYMAN ST, POST OFFICE BOX 9046, WALTHAM MA 02454
Syed A. Jafry officer: Sr. Vice President 345 E. MAIN STREET, WARSAW IN 46580